KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Gross Margin (2016 - 2025)

Historic Gross Margin for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to 42.24%.

  • Fulgent Genetics' Gross Margin rose 49300.0% to 42.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 41.24%, marking a year-over-year increase of 50300.0%. This contributed to the annual value of 37.82% for FY2024, which is 17100.0% up from last year.
  • Latest data reveals that Fulgent Genetics reported Gross Margin of 42.24% as of Q3 2025, which was up 49300.0% from 42.1% recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Gross Margin registered a high of 80.92% during Q3 2021, and its lowest value of 19.18% during Q4 2022.
  • In the last 5 years, Fulgent Genetics' Gross Margin had a median value of 42.1% in 2025 and averaged 48.32%.
  • In the last 5 years, Fulgent Genetics' Gross Margin skyrocketed by 317200bps in 2021 and then tumbled by -561300bps in 2022.
  • Over the past 5 years, Fulgent Genetics' Gross Margin (Quarter) stood at 75.31% in 2021, then plummeted by -75bps to 19.18% in 2022, then surged by 87bps to 35.78% in 2023, then increased by 17bps to 41.79% in 2024, then increased by 1bps to 42.24% in 2025.
  • Its last three reported values are 42.24% in Q3 2025, 42.1% for Q2 2025, and 38.59% during Q1 2025.